GSK239512 DDI Study

Clinical trial NCT01802931 · COMPLETED

Trial details

NCT number: NCT01802931
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2013-01-07
Primary completion: 2013-04-15
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.